Robert Lutz
Geschäftsführer bei SAVARA INC.
Vermögen: 250 $ am 31.05.2024
Aktive Positionen von Robert Lutz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SAVARA INC. | Geschäftsführer | 13.02.2023 | - |
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Corporate Officer/Principal | - | - |
Karriereverlauf von Robert Lutz
Ehemalige bekannte Positionen von Robert Lutz
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IBIO, INC. | Finanzdirektor/CFO | 01.09.2019 | 10.02.2023 |
STRONGBRIDGE BIOPHARMA | Finanzdirektor/CFO | 03.09.2019 | 03.03.2021 |
Corporate Officer/Principal | 01.10.2014 | 03.09.2019 | |
Cinergy Corp.
Cinergy Corp. Electric UtilitiesUtilities Cinergy Corp. used to supply electricity and gas. It also developed, owned and operated electric generation for large energy consumers, municipalities, utilities and industrial facilities. The company was located in Cincinnati, OH. | Corporate Officer/Principal | 01.08.1997 | 01.01.2003 |
Ausbildung von Robert Lutz
Kellogg School of Management | Masters Business Admin |
Amherst College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Corporate Officer/Principal | 3 |
Director of Finance/CFO | 2 |
Masters Business Admin | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
IBIO, INC. | Health Technology |
SAVARA INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Cortendo AB
Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Commercial Services |
Strongbridge Biopharma Plc
Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
Cinergy Corp.
Cinergy Corp. Electric UtilitiesUtilities Cinergy Corp. used to supply electricity and gas. It also developed, owned and operated electric generation for large energy consumers, municipalities, utilities and industrial facilities. The company was located in Cincinnati, OH. | Utilities |
- Börse
- Insiders
- Robert Lutz
- Erfahrung